Please login to the form below

Not currently logged in
Email:
Password:

CombiHIVvac

This page shows the latest CombiHIVvac news and features for those working in and with pharma, biotech and healthcare.

HIV vaccine from J&J starts human trials

HIV vaccine from J&J starts human trials

Scarcity of funding is also threatening a Russian HIV vaccine candidate called CombiHIVvac, which is heading for phase II testing.

Latest news

  • Russian HIV vaccine heading for phase II trials Russian HIV vaccine heading for phase II trials

    trial of CombiHIVvac still needs to be approved by the government, reports the RIA Novosti news agency. ... Mikheyev told reporters that the phase II trials planned for CombiHIVvac could take around two years to complete, provided funding can be found.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics